Please assess the completion status of the following clinical trial:

Trial Title: Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~General inclusion criteria (case and control):~* No gender criteria~* Age \> 25 years.~* Legal competency.~* Ability to comply with the proposed protocol schedule.~* Stability of chronic medical diseases.~* A negative validated pregnancy test for fertile female participants prior to project enrolment.~* Use of validated anti-conception for fertile female participants~Case-specific inclusion criteria:~* Well-defined neuropathic pain \[21\].~* Chronic and stable pain condition. Numerical Rating Scale score \> 5.~* Documented resistance to, or poor tolerance of pharmacological treatments. Unless contraindicated, the treatment must have included opiate derivatives, tri-cyclic antidepressants and anti-epileptic drugs.~Exclusion Criteria:~General exclusion criteria:~* Pregnancy or nursing.~* Cognitive impairment.~* Alcohol or drug abuse~* Severe psychiatric disorders.~* Allergies towards compounds used in the trial, such as PET tracers, Capsaicin, etc. Other significant medical allergies.~* Severe medical disorders~* Neurodegenerative disorders~* Severe cerebrovascular diseases and risk-factors, malignant hypertension, vascular abnormalities.~* Prior intracranial surgery~* Cardiac pacemaker or other implanted electronic medical devices~* Coagulopathy (excl. drug induced)~* Structural brain abnormalities~* Epilepsy or prior isolated seizure.~* Severe obesity~* Severe claustrophobia~* Magnetic metallic implants~* Other conditions that may contraindicate deep brain stimulation surgery, full anesthesia, transcranial magnetic stimulation, PET/CT imaging (specifically the use of carfentanil) or magnetic resonance imaging. This will be evaluated according to specific investigational product specifications and clinical guidelines.~Control specific exclusion criteria:~- Chronic pain syndrome

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Sham-DBS (Type: SHAM_COMPARATOR): Only patients. Inactive deep brain stimulation for the initial three months following implantation.
- Active DBS (Type: ACTIVE_COMPARATOR): Only patients. Active deep brain stimulation for the initial three months following surgery.
- TMS and PET imaging (Type: EXPERIMENTAL): This experiment includes all participants (cases and controls). Each subject will undergo both active and sham stimulation (cross-over) with Cervel Neurotech Multi-coil TMS and related test/re-test PET imaging with 11C-Carfentanil. Only patients will proceed into deep brain stimulation experiments.

Based on this trial design, predict the completion outcome and termination type (if applicable).